- ZYUS Life Sciences Receives Cannabis Drug License from Health Canada
- INSERTING and REPLACING ZYUS Life Sciences Corporation to Present at Sidoti Virtual Investor Conference May 8-9
- ZYUS Announces Completion of Its Annual Filings
- ZYUS Announces Anticipated Delay in Its Annual Filings
- ZYUS Life Sciences Receives United States Patent No. 11,963,943 Covering Pain Management
More ▼
Key statistics
On Friday, ZYUS Life Sciences Corp (ZYUS:CVE) closed at 1.03, -13.45% below its 52-week high of 1.19, set on May 08, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 1.01 |
---|---|
High | 1.03 |
Low | 0.99 |
Bid | 0.99 |
Offer | 1.03 |
Previous close | 1.04 |
Average volume | 6.28k |
---|---|
Shares outstanding | 70.85m |
Free float | 32.68m |
P/E (TTM) | -- |
Market cap | 72.97m CAD |
EPS (TTM) | -0.5751 CAD |
Data delayed at least 15 minutes, as of Jul 05 2024 16:47 BST.
More ▼